Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after market close. Here’s what investors should know. Masimo beat analysts’ revenue expectations by 1.5% last ...

Meanwhile, MASI’s guidance for 2024 also implies flat to declining sales for non-healthcare business in 2024. The healthcare segment sales were down 4% at cc in 2023, while the company estimates ...